Drug-Drug Interactions Between ADHD and Cardiometabolic Medications: a Pharmacovigilance Study

First published 03/10/2025

Last updated 03/10/2025

EU PAS number:

EUPAS1000000761

Study

Planned

Download as PDF

Documents

Study protocol

Updated protocol

Common analysis protocol_DDI between ADHD and cardiometabolic medications.pdf

First published: 01/10/2025

English (343.85 KB - PDF) View document

Study results

Study report

Other information